More transparency and precise time limits for decision-making on pricing and reimbursement of medicines

More transparency and precise time limits for decision-making on pricing and reimbursement of medicines are needed to improve patients’ access to affordable treatments and prevent barriers to getting medicines to market, said Environment and Public Health Committee MEPs voting on draft legislation on Tuesday. Details from the ENVI committee vote available here.

Published on 18. December 2012 in News EU